Degradation of Top2b and Top2a in Human by Dexrazoxane

Clinical trial pipeline · Data from ClinicalTrials.gov

Total trials

Actively recruiting

Phase 3 trials

Completed

The purpose of this research study is to determine whether early administration of Dexrazoxane prevents Doxorubicin induced cardiotoxicity.